Relevium Provides Update on Newscope Transacion
January 28, 2020 09:15 ET
|
Relevium Technologies Inc
MONTREAL, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an update on the...
Relevium’s CEO Provides an Open Shareholder Letter for 2020
December 19, 2019 09:14 ET
|
Relevium Technologies Inc
MONTREAL, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an open letter to its...
Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
November 08, 2019 08:35 ET
|
Relevium Technologies Inc
MONTREAL, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a...
Relevium Enters Into LOI to Unlock Value of Wholly Owned Subsidiary BGX E-Health LLC and Announces Conference Call With CEO
October 29, 2019 09:22 ET
|
Relevium Technologies Inc
MONTREAL, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce On October 25, 2019,...
Relevium Announces Intention to Spin-Out Pediatric Cannabis Subsidiary Biocannabix
September 19, 2019 08:34 ET
|
Relevium Technologies Inc
MONTREAL, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces its intention to create a new,...
Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients
July 10, 2019 09:30 ET
|
Relevium Technologies Inc
MONTREAL, July 10, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has executed an...
Relevium to Hold Investor Call to Discuss LATAM Strategy June 28, 2019 at 1:00pm EST
June 19, 2019 08:30 ET
|
Relevium Technologies Inc
MONTREAL, June 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or...
Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia
June 13, 2019 09:54 ET
|
Relevium Technologies Inc
MONTREAL, June 13, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that Biocannabix...
Relevium Closes Private Placement Financing
June 11, 2019 17:51 ET
|
Relevium Technologies Inc
MONTREAL, June 11, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has closed a...
Relevium’s Biocannabix Executes LOI to Acquire 30% Interest in Weedsense, a Late Stage Applicant for Standard Processing and Medical Sales License
June 05, 2019 09:46 ET
|
Relevium Technologies Inc
MONTREAL, June 05, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly owned...